ALUME BIOSCIENCES INC

Profile

Company Names

ALUME BIOSCIENCES INC

Addresses

2223 AVENIDA DE LA PLAYA, SUITE 205, LA JOLLA, CA 92037

3210 MERRYFIELD ROW, SAN DIEGO, CA 92121

Phone Numbers

858-254-7116

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$35,545,278.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2026-03-24 
$2,160,000.00 
$8,000,000.00 
$5,840,000.00 
 
5
2025-10-30 
$6,853,305.00 
$23,499,998.00 
$16,646,693.00 
Equity 
4
2022-12-28 
$12,759,950.00 
$45,024,930.00 
$32,264,980.00 
Equity 
3
2022-04-01 
$4,000,000.00 
$5,225,000.00 
$1,225,000.00 
 
2
2020-08-21 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
1
2019-06-28 
$5,772,023.00 
$8,571,156.00 
$2,799,133.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRETT 
 
BERMAN 
EXECUTIVE OFFICER, DIRECTOR
UMETIME, INC.   |  ALUME BIOSCIENCES INC
DAN 
 
BRADBURY 
DIRECTOR
FREEDOM MEDITECH INC   |  MICRODERMIS CORP   |  FREEDOM MEDITECH, INC   |  ALUME BIOSCIENCES INC   |  BIOLINQ INC
KIM 
 
KAMDAR 
DIRECTOR
NUON THERAPEUTICS INC   |  ALTAIR THERAPEUTICS, INC.   |  TANDEM TECHNOLOGIES, INC.   |  ROX MEDICAL INC   |  SERA PROGNOSTICS, INC.   |  ARIA DIAGNOSTICS, INC.   |  DOMAIN PARTNERS IX, L.P.   |  EVOFEM BIOSCIENCES, INC.   |  ALUME BIOSCIENCES INC   |  SAVANNA BIOTHERAPEUTICS, INC.
MAGDA 
 
MARQUET 
DIRECTOR
ALTHEADX, INC.   |  ALTHEA TECHNOLOGIES INC   |  SENTE INC   |  INDEPENDA, INC.   |  ALUME BIOSCIENCES INC   |  PROCISEDX INC.   |  MATRISYS BIOSCIENCE, INC.   |  IMMIX BIOPHARMA, INC.   |  TRANSCODE THERAPEUTICS, INC.   |  ACURION, INC.
JEAN-PIERRE 
 
MILLION 
DIRECTOR
ALUME BIOSCIENCES INC
JEAN-PIERRE 
 
MILLON 
DIRECTOR
TUMMY COMPANY, INC.   |  TRIPLE AIM VENTURES, LLC   |  INANOBIO, INC.   |  ALUME BIOSCIENCES INC
QUYEN 
 
NGUYEN 
EXECUTIVE OFFICER, DIRECTOR
ALUME BIOSCIENCES INC
QUYEN 
T 
NGUYEN 
EXECUTIVE OFFICER, DIRECTOR
ALUME BIOSCIENCES INC
QUYEN 
T. 
NGUYEN 
EXECUTIVE OFFICER, DIRECTOR
ALUME BIOSCIENCES INC
KAVERI 
 
PARKER 
EXECUTIVE OFFICER
ID GENOMICS INC.   |  ID GENOMICS SPC   |  SYNEDGEN, INC.   |  ALUME BIOSCIENCES INC
JAMES 
 
SCHMIDT 
EXECUTIVE OFFICER
RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)   |  RECEPTOS, INC.   |  SALVEO DX, INC.   |  ALUME BIOSCIENCES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2026-03-24 
2026-04-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2026-03-24 
2026-02-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-30 
2026-01-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-30 
2025-12-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-30 
2025-11-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-30 
2025-10-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-30 
2023-01-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-28 
2022-09-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-04-01 
2022-04-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-04-01 
2020-08-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-21 
2019-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PHX FINANCIAL INC.
144403